Valuing risk: The ethical review of clinical trial safety

Kennedy Institute of Ethics Journal

Volumn 14, Issue 4, 2004, Pages 369-393

  Kimmelman, Jonathan ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; ADVISORY COMMITTEE; CLINICAL TRIAL; CONCEPT FORMATION; EXPERIMENTAL HOST; EXPERIMENTAL MODEL; EXPERT SYSTEM; INFECTION RISK; MEDICAL ETHICS; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; STANDARD; UTILIZATION REVIEW; VIRUS INFECTION;

EID: 13144307091     PISSN: 10546863     EISSN: None     Source Type: Journal    
DOI: 10.1353/ken.2004.0041     Document Type: Review

References (58)

1. Adams, John. 1995. Risk. London: UCL Press.
2. Baram, Michael. 2001. Making Clinical Trials Safer for Human Subjects. American Journal of Law and Medicine 27: 253-82.
3. Barnes, Deborah E., and Bero, Lisa A. 1998. Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions. JAMA 279: 1566-70.
4. Bauer, Patricia E. 2001. A Few Simple Truths about Your Community IRB Members. IRB: A Review of Human Subjects Research 23 (1): 7-8.
5. Beck, Ulrich. 1992. Risk Society: Towards a New Modernity. London: Sage Publications.
6. Bell, James; Whiton, John; and Connelly, Sharon, (James Bell Associates). 1998. Final Report: Evaluation of NIH Implementation of Section 491 of the Public Health Service Act, Mandating a Program of Protection of Research Subjects. Washington, DC: Office of Extramural Research, National Institutes of Health. Available at http://ohrp.osophs.dhhs.gov/hsp_report/hsp_ final_rpt.pdf. Accessed 5 December 2003.
7. Campbell, Eric G.; Clarridge, Brian R.; Gokhale, Manjusha; et al. 2002. Data Withholding in Academic Genetics: Evidence From a National Survey. JAMA 287: 473-80.
8. Campbell Eric G.; Weissman, Joel S.; Clarridge, Brian; et al. 2003. Characteristics of Medical School Faculty Members Serving on Institutional Review Boards: Results of a National Survey. Academic Medicine 78: 831-36.
9. Cho, Mildred K., and Billings, Paul. Conflict of Interest and Institutional Review Boards. 1997. Journal of Investigative Medicine 45 (4): 154-59.
10. Dettweiler, Ulrich, and Simon, Perikles. 2001. Points to Consider for Ethics Committees in Human Gene Therapy Trials. Bioethics 15: 491-500.
11. DHHS, NIH. 2000. RAC Minutes of Meeting March 8-10. Available at hhtp://www4.od.nih.gov/oba/rac/minutes/RACmin3-00.htm#CIII. Accessed 2 July 2002.
12. _. 2001. RAC Minutes of Meeting December 6. Available at hhtp:// www4.od.nih.gov/oba/rac/minutes/Dec01minutes.pdf. Accessed 4 December 2003.
13. Douglas, Mary, and Wildavsky, Aaron. 1982. Risk and Culture: an Essay on the Selection of Technological and Environmental Dangers. Berkeley: University of California Press.
14. Epstein, Steven. 2000. Democracy, Expertise, and AIDS Treatment Activism. In Science, Technology, & Democracy, ed. Daniel Lee Kleinman, pp. 15-32. Albany: State University of New York Press.
15. Finucane, Melissa L.; Alhakami, Ali; Slovic, Paul; and Johnson, Stephen M. 2000. The Affect Heuristic in Judgments of Risks and Benefits. Journal of Behavioral Decision Making 13 (1): 1-17.
16. Giddens, Anthony. 1991. Modernity and Self-Identity. Cambridge: Polity Press.
17. _. 2003. Runaway World: How Globalization Is Reshaping Our Lives. New York: Routledge Press.
18. Goldman, Jerry J., and Katz, Martin D. 1982. Inconsistency and Institutional Review Boards. JAMA 248: 197-202.
19. Gutmann, Amy, and Thompson, Dennis. 1997. Deliberating about Bioethics. Hastings Center Report 27 (3): 38-41.
20. Hayes, Gregory J.; Hayes, Steven C.; and Dykstra, Thane. 1995. A Survey of University Institutional Review Boards: Characteristics, Policies, and Procedures. IRB: A Review of Human Subjects Research 17 (3): 1-6.
21. Hirshon, Jon M.; Krugman, Scott D.; Witting, Michael D.; et al. 2002. Variability in Institutional Review Board Assessment of Minimal-risk Research. Academic Emergency Medicine 9: 1417-20.
22. Holm, Søren. 1992. How Many Lay Members Can You Have in Your IRB? - An Overview of the Danish System. IRB: A Review of Human Subjects Research 14 (6): 8-11.
23. Institute of Medicine. Committee on Assessing the System of Protecting Human Research Participants. 2003. Responsible Research: A Systems Approach to Protecting Research Participants, ed. Daniel E. Federman, Kathi E. Hanna, and Lana Lyman Rodriguez. Washington, DC: National Academies Press.
24. Jasanoff, Sheila. 1994. Introduction: Learning from Disaster. In Learning from Disaster: Risk Management after Bhopal, ed. Sheila Jasanoff, pp. 1-21. Philadelphia: University of Pennsylvania Press.
25. Karlawish, Jason H. T., and Lantos, John. 1997. Community Equipoise and the Architecture of Clinical Research. Cambridge Quarterly of Healthcare Ethics 6: 385-96.
26. Kay, Mark A.; Manno, Catherine S.; Ragni, Margaret V.; et al. 2000. Evidence for Gene Transfer and Expression of Factor IX in Haemophilia B Patients Treated with an AAV Vector. Nature Genetics 24: 257-61.
27. Kent, Gerry. 1997. The Views of Members of Local Research Ethics Committees, Researchers and Members of the Public Towards the Roles and Functions of LRECs. Journal of Medical Ethics 23: 186-90.
28. King, Nancy M. P. 2002. RAC Oversight of Gene Transfer Research: A Model Worth Extending? Journal of Law, Medicine and Ethics 30: 381-89.
29. Klee, Robert. 1997. Introduction to the Philosophy of Science: Cutting Nature at its Seams. New York: Oxford University Press.
30. Kopelman, Loretta M. 2000. Moral Problems in Assessing Research Risks. IRB: A Review of Human Subjects Research 22 (5): 3-6.
31. Kraus, Nancy; Malmfors, Torbjörn; and Slovic, Paul. 2000. Intuitive Toxicology: Expert and Lay Judgement of Chemical Risks. In The Perception of Risk, ed. Paul Slovic, pp. 285-315. Sterling, VA: Earthscan.
32. Levine, Robert J. 1986. Ethics and Regulation of Clinical Research. 2d ed. New Haven: Yale University Press.
33. Lynn, Frances M. 1987. OSHA's Carcinogens Standard: Round One on Risk Assessment Models and Assumptions. In The Social and Cultural Construction of Risk, ed. Brandon B. Johnson and Vincent T. Covello, pp. 345-58. Boston: Reidel.
34. Martin, Douglas K.; Meslin, Eric M.; Kohut, Nitsa; and Singer, Peter A. 1995. The Incommensurability of Research Risks and Benefits: Practical Help for Research Ethics Committees. IRB: A Review of Human Subjects Research 17 (2): 8-10.
35. McWilliams, Rita; Hoover-Fong, Julie; Hamosh, Ada; et al. 2003. Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study. JAMA 290: 360-66.
36. Melton, Gary B.; Levine, Robert J.; Koocher, Gerald P.; et al. 1988. Community Consultation in Socially Sensitive Research. American Psychologist 43: 573-81.
37. Meslin, Eric M. 1990. Protecting Human Subjects From Harm Through Improved Risk Judgments. IRB: A Review of Human Subjects Research 12 (1): 7-10.
38. Miller, Paul B., and Weijer, Charles. 2000. Moral Solutions in Assessing Research Risk. IRB: A Review of Human Subjects Research 22 (5): 6-10.
39. _. 2003. Rehabilitating Equipoise. Kennedy Institute of Ethics Journal 13: 93-118.
40. Moreno, Jonathan D. 1998. IRBs under the Microscope. Kennedy Institute of Ethics Journal 8: 329-37.
41. National Commission. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1977. Report and Recommendations: Research Involving Children. Washington, DC: DHEW.
42. _. 1979. Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: U.S. Government Printing Office.
43. NBAC. National Bioethics Advisory Commission. 1998. Research Involving Persons with Mental Disorders Affecting Decisionmaking Capacity: Report and Recommendations. Rockville, MD: NBAC.
44. _. 2001. Ethical and Policy Issues in Research Involving Human Participants. Volume I: Report and Recommendations of NBAC. Bethesda, MD: NBAC.
45. Prentice, Ernest D., and Gordon, Bruce G. 2001. Institutional Review Board Assessment of Risks and Benefits Associated with Research. In Ethical and Policy Issues in Research Involving Human Participants. Volume II: Report and Recommendations of NBAC, National Bioethics Advisory Commission, L1-L16. Bethesda, MD.
46. Redelmeier, Donald A.; Rozin, Paul; and Kahneman, Daniel. 1993. Understanding Patients' Decisions: Cognitive and Emotional Perspectives. JAMA 270: 72-76.
47. Sengupta, Sohini, and Lo, Bernard. 2003. The Roles and Experiences of Nonaffiliated and Non-Scientist Members of Institutional Review Boards. Academic Medicine 78: 212-18.
48. Siegrist, Michael, and Cvetkovich, George. 2000. Perception of Hazards: The Role of Social Trust and Knowledge. Risk Analysis 20: 713-19.
49. Silverman, Henry; Hull, Sara C.; and Sugarman, Jeremy. 2001. Variability among Institutional Review Boards' Decisions Within the Context of a Multicenter Trial. Critical Care Medicine 29: 235-41.
50. Slovic, Paul. 1987. Perception of Risk. Science 236: 280-85.
51. _. 1999. Trust, Emotion, Sex, Politics, and Science: Surveying the Risk-Assessment Battlefield. Risk Analysis 19: 689-701.
52. Stair, Thomas O.; Reed, Cailin R.; Radeos, Michael S.; et al. 2001. Variation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Clinical Trial. Academic Emergency Medicine 8: 636-40.
53. Steinbrook, Robert. 2002. Improving Protection for Research Subjects. New England Journal of Medicine 346: 1425-30.
54. Strauss, Ronald P.; Sengupta, Sohini; Quinn, Sandra C.; et al. 2001. The Role of Community Advisory Boards: Involving Communities in the Informed Consent Process. American Journal of Public Health 91: 1938-43.
55. Tricouncil Policy Statement. 2003. Ethical Conduct for Research Involving Humans. Ottawa, Canada: MRC, NSERC, and SSHRC.
56. Weijer, Charles. 1999. Thinking Clearly about Research Risk: Implications of the Work of Benjamin Freedman. IRB: A Review of Human Subjects Research 21 (6): 1-5.
57. Williams, Peter C. 1984. Why IRBs Falter in Reviewing Risks and Benefits. IRB: A Review of Human Subjects Research 6 (3): 1-4.
58. Wynne, Brian. 1988. Unruly Technology: Practical Rules, Impractical Discourses and Public Understanding. Social Studies of Science 18: 147-67.